Mario Testino’s ‘Master Class’ Resonates for Women’s Rights in 2024 Election
/
US Supreme Court Halts Texas District Court Ruling on Mifepristone, Appeal Proceeds
/
Today’s order halted both the Texas District decision and the procedural appeal in the U.S. Court of Appeals for the Fifth Circuit.
For now, the abortion pill mifepristone will remain widely available, but it has a court date of May 17th for oral arguments.
Gov. Jay Inslee of Washington called the ruling a “half step in the right direction.” Washington is among the states stockpiling mifepristone — an estimated four-year-supply. “This dubious challenge to the availability of a safe medication never should have gone as far as it has, and it must be rejected entirely,” he said Friday.
Read MoreSupreme Court Issues Stay On Texas Mifepristone Decision | Responses Due Tuesday
/
On Friday, U.S. Supreme Court Justice Samuel Alito issued an administrative stay on the Texas court ruling concerning the abortion medication mifepristone. This came after the Justice Department announced on Thursday that it would seek emergency relief from the Supreme Court to defend the Food and Drug Administration's (FDA) approval of the pill and protect Americans' access to safe and effective reproductive care.
Justice Samuel Alito signed the order asking both sides to file briefs by Tuesday over which parts of U.S. District Judge Matthew Kacsmaryk’s April 7 Amarillo, Texas ruling should be left standing — if any — while the court considers the case.
In addition to the Biden Administration, New York-based Danco Laboratories, the maker of the pill, asked the justices to intervene.
Read More400 Pharma and Biotech Companies Issue 'Scorching Condemnation' of Texas Mifepristone Ruling
/
Scientists and senior executives from more than 400 pharmaceutical and biotech companies and also investment firms issued what the New York Times called a “scorching condemnation” of the ruling of Texas District Judge Matthew Kacsmaryk issued late Friday, April 7th that invalidated the Food and Drug Administration’s 23-year-old approval of the abortion pill mifepristone.
Titled “In Support of FDA’s Authority to Regulate Medicines”, the letter excerpts shared on AOC read:
On Friday, April 7, a federal judge with no scientific training fundamentally undermined the bipartisan authority granted by Congress to the Food and Drug Administration to approve and regulate safe, effective medicines for every American.
District Judge Matthew Kacsmaryk issued a decision that overturns the 23-year old approval of mifepristone, the primary medicine used in abortion and miscarriage care, and which has been proven by decades of data to be safer than Tylenol, nearly all antibiotics and insulin.
The decision ignores decades of scientific evidence and legal precedent. Judge Kacsmaryk’s act of judicial interference has set a precedent for diminishing FDA’s authority over drug approvals, and in so doing, creates uncertainity for the entire biopharma industry . . .
As American citizens and interested parties, we are invited to add our names to the letter. Anne of Carversville has signed on to the simple Google doc. Texas District Judge Matthew Kacsmaryk’s assault on science and a key federal institution deeply embedded in American life — the FDA — was even more chilling to me as an American citizen than the June 24, 2022 Dobbs decision that overturned the nearly five-decades-old Roe v Wade decision.
Read MoreWSJ Condemns New York's 'Massive Resistance' to SC Guns Galore Across America Ruling
/
